Not a good quarter for Pfizer (PFE). Second quarter revenue fell 6% to $11.1 billion. Net income was down 48% to $1.3 billion.
The loss of U.S. exclusivity for Zoloft and Norvasc hurt earnings as did Lipitor’s performance in the U.S. The company did say it thought it could still reach its financial goals for 2007 and 2008. Lipitor sales fell 13% worldwide and 25% in the US. Zoloft sales worldwide were down 82%.
The generics are tearing Pfizer up. At least for now.
Douglas A. McIntyre
Take This Retirement Quiz To Get Matched With An Advisor Now (Sponsored)
Are you ready for retirement? Planning for retirement can be overwhelming, that’s why it could be a good idea to speak to a fiduciary financial advisor about your goals today.
Start by taking this retirement quiz right here from SmartAsset that will match you with up to 3 financial advisors that serve your area and beyond in 5 minutes. Smart Asset is now matching over 50,000 people a month.
Click here now to get started.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Editors' Picks
